Eptacog alfa biosimilar - International Biotech Center Generium

Drug Profile

Eptacog alfa biosimilar - International Biotech Center Generium

Alternative Names: Coagyl VII; GNR-001; Human blood coagulation factor VII

Latest Information Update: 03 Mar 2017

Price : $50

At a glance

  • Originator International Biotech Center Generium
  • Developer International Biotechnology Center Generium
  • Class Antihaemorrhagics; Blood coagulation factors; Recombinant proteins
  • Mechanism of Action Factor VIIa stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Registered Haemophilia A; Thrombasthenia

Most Recent Events

  • 27 Oct 2015 Registered for Haemophilia A in Russia (IV) before October 2015
  • 26 Oct 2015 Preregistration for Haemophilia A in Russia (IV) before October 2015
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top